Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.68 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.68 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.68 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.68 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.68 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.57 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.56 |
| ▸ | PPARG | P37231 | 7/20 | 0.56 |
| ▸ | PPARD | Q03181 | 7/20 | 0.56 |
| ▸ | PPARA | Q07869 | 7/20 | 0.56 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.56 |
| ▸ | TSHR | P16473 | 4/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.56 |
| ▸ | TLR2 | O60603 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | FABP4 | P15090 | 2/20 | 0.56 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.56 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butyric Acid SCHEMBL11355516 | 0.97 | FFAR3 (0.65) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL7777837 | 0.97 | FFAR3 (0.65) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL27959816 | 0.95 | FFAR3 (0.62) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL28175671 | 0.95 | FFAR3 (0.62) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL8603917 | 0.95 | FFAR3 (0.62) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Heptane SCHEMBL28449904 | 0.95 | GPR84 (0.65) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL17078357 | 0.93 | FFAR3 (0.59) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL6684753 | 0.93 | FFAR3 (0.59) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL8727435 | 0.93 | FFAR3 (0.59) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL30473397 | 0.92 | FFAR3 (0.65) | FFAR3HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080183011-A1 | Process for preparation of perindopril erbumine in alpha crystalline form | IPCA LABORATORIES LIMITED | 2008-07-31 | — | — | US | claimed |
| EP-0879058-B1 | MIXTURES DERIVED FROM GRAINS OF EUGENIA JAMBOLANA LAMARCK, PREPARATION AND USE OF SAID MIXTURES AND SOME OF THEIR CONSTITUENTS AS MEDICAMENTS | INST MALGACHE DE RECH S APPLIQ (MG) | 2001-06-06 | — | — | EP | claimed |
| US-11584914-B2 | Processes for producing organic solvents using Clostridium saccharoperbutylacetonicum | BIOCLEAVE LIMITED (GB) | 2023-02-21 | — | — | US | disclosed |
| US-20210189325-A1 | PROCESSES INVOLVING CLOSTRIDIUM SACCHAROPERBUTYLACETONICUM | BIOCLEAVE LIMITED (GB) | 2021-06-24 | — | — | US | disclosed |
| EP-3694983-A1 | PROCESSES INVOLVING CLOSTRIDIUM SACCHAROPERBUTYLACETONICUM | Biocleave Limited (GB) | 2020-08-19 | — | — | EP | disclosed |
| CN-104293840-B | A method of improving esterification by lipase reaction vigor and recycling | 丰益(上海)生物技术研发中心有限公司 | 2019-06-07 | — | — | CN | disclosed |
| WO-2019073254-A1 | PROCESSES INVOLVING CLOSTRIDIUM SACCHAROPERBUTYLACETONICUM | GREEN BIOLOGICS LIMITED (GB) | 2019-04-18 | — | — | WO | disclosed |
| CN-104955938-B | Recombinant microorganism and its production method comprising NADPH dependent enzymes | 朗泽科技新西兰有限公司 | 2018-03-02 | — | — | CN | disclosed |
| EP-2630247-B1 | PRODUCTION OF BUTANOL FROM CARBON MONOXIDE BY A RECOMBINANT MICROORGANISM | LANZATECH NEW ZEALAND LTD (NZ) | 2017-03-15 | — | — | EP | disclosed |
| EP-3066069-A1 | METHOD FOR SYNTHESISING ESTERS AND CATALYST FOR SAID SYNTHESIS | Pivert (FR) | 2016-09-14 | — | — | EP | disclosed |
| US-9359611-B2 | Recombinant microorganism and methods of production thereof | LANZATECH NEW ZEALAND LIMITED (NZ) | 2016-06-07 | — | — | US | disclosed |
| WO-2003060113-A1 | BIOREACTOR | SILBIOTEC DUE S.A. (LU) | 2003-07-24 | — | — | WO | disclosed |
| US-5425422-A | Injecting deasphalted oil into well, soaking to solubilize deposits, resuming oil production | NORANDA INC. (CA) | 1995-06-20 | — | — | US | disclosed |
| US-4954483-A | BACTERICIDE, ANIMAL GROWTH PROMOTER | GRUPPO LEPETIT, S.P.A. (IT) | 1990-09-04 | — | — | US | disclosed |
| EP-0216775-B1 | CARBOXYLIC ACID ESTER DERIVATIVES OF DEGLUCOTEICOPLANIN | GRUPPO LEPETIT S.p.A. (IT) | 1989-05-03 | — | — | EP | disclosed |
| EP-0216775-A1 | CARBOXYLIC ACID ESTER DERIVATIVES OF DEGLUCOTEICOPLANIN. | LEPETIT SPA (IT) | 1987-04-08 | — | — | EP | disclosed |
| EP-0062919-B1 | INDOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-07-30 | — | — | EP | disclosed |
| WO-1986000075-A1 | CARBOXYLIC ACID ESTER DERIVATIVES OF DEGLUCOTEICOPLANIN | GRUPPO LEPETIT S.P.A. (IT) | 1986-01-03 | — | — | WO | disclosed |
| EP-0062919-A1 | Indole derivatives, process for their preparation and pharmaceutical compositions containing them | SCHERING AKTIENGESELLSCHAFT (DE) | 1982-10-20 | — | — | EP | disclosed |
| US-3956260-A | ANTIINFLAMMATORY | CIBA-GEIGY CORPORATION (US) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080183011-A1 | Process for preparation of perindopril erbumine in alpha crystalline form | ACE, REN, ADH1C | FFAR3 1282/4885HDAC3 816/4885HDAC1 734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.